Rapid Response Revival is dedicated to improving the design, portability, cost and ease-of-use of automated external defibrillators (AEDs). AEDs save lives. Their purpose is to make early defibrillation available to people experiencing out-of-hospital cardiac arrest (OHCA). Globally, more than six million people die every year from sudden cardiac arrest, with a survival rate of less than 1 per cent.1 Most of these deaths – more than 80 per cent – occur in homes.2 Rapid Response Revival is pioneering a solution to barriers to AED use and home ownership, including portability, ease of use, and cost. That solution is CellAED®.
Rapid Response Revival is currently undergoing rigorous assessments required of medical device regulators around the world.
CellAED® achieved CE Certification in May 2021, which applies to Member States of the European Economic Area and is also approved for sale in the United Kingdom, Australia, New Zealand and Taiwan.
Rapid Response Revival is actively seeking regulatory approval for CellAED® in other jurisdictions around the world.
How it works
It’s as easy as SNAP PEEL STICK®. Designed to be applied in seconds, CellAED® can be used by a person with minimal training.
CellAED® is activated by snapping the device in half, which immediately starts audio voice prompts instructing the user to call for help and place the pads on the patient’s bare chest.
CellAED® then immediately analyses the patient’s heart rhythm. Voice prompts will instruct the user on what to do, every step of the way. CellAED® will only deliver a shock if a heart rhythm associated with sudden cardiac arrest is detected.